{
  "inputs": [],
  "outputs": [
    {
      "name": "Admit via A&E/Medics",
      "description": "Patient requires admission via A&E/Medics"
    },
    {
      "name": "Metformin",
      "description": "Start Metformin treatment"
    },
    {
      "name": "SGLT2i",
      "description": "Start SGLT2i treatment as tolerated add-on after 4 weeks"
    },
    {
      "name": "Gliptin or Pioglitazone or Gliclazide",
      "description": "Start dual therapy with one of these medications"
    },
    {
      "name": "Metformin + Gliptin/Pioglitazone/Gliclazide (consider SGLT2i)",
      "description": "Start triple therapy"
    },
    {
      "name": "Add GLP",
      "description": "Add GLP-1 agonist to treatment regimen"
    },
    {
      "name": "Ozempic",
      "description": "Start Ozempic (high prognostic value)"
    },
    {
      "name": "Mounjaro",
      "description": "Start Mounjaro (low prognostic value)"
    },
    {
      "name": "Ozempic titrate to full dose with 3 monthly A1cs",
      "description": "Titrate Ozempic to full dose with monitoring"
    },
    {
      "name": "Refer to Insulin Initiator",
      "description": "Refer patient for insulin initiation"
    }
  ],
  "tree": {
    "start": {
      "id": "start",
      "type": "start",
      "label": "Start Gliclazide or Insulin",
      "children": [
        {
          "id": "d1",
          "type": "decision",
          "label": "Admission required?",
          "input_ids": [],
          "edge_label": "",
          "children": [
            {
              "id": "o1",
              "type": "output",
              "label": "Admit via A&E/Medics",
              "edge_label": "Yes"
            },
            {
              "id": "d2",
              "type": "decision",
              "label": "Treatment Algorithm",
              "input_ids": [],
              "edge_label": "No",
              "children": [
                {
                  "id": "a1",
                  "type": "action",
                  "label": "Metformin",
                  "edge_label": "*CVD Known or Risk",
                  "children": [
                    {
                      "id": "d3",
                      "type": "decision",
                      "label": "Tolerated add-on after 4 weeks",
                      "input_ids": [],
                      "edge_label": "",
                      "children": [
                        {
                          "id": "a2",
                          "type": "action",
                          "label": "SGLT2i",
                          "edge_label": "",
                          "children": [
                            {
                              "id": "d4",
                              "type": "decision",
                              "label": "A1c not controlled",
                              "input_ids": [],
                              "edge_label": "",
                              "children": [
                                {
                                  "id": "a3",
                                  "type": "action",
                                  "label": "Ozempic titrate to full dose with 3 monthly A1cs",
                                  "edge_label": "",
                                  "children": [
                                    {
                                      "id": "d5",
                                      "type": "decision",
                                      "label": "A1c not controlled",
                                      "input_ids": [],
                                      "edge_label": "",
                                      "children": [
                                        {
                                          "id": "o2",
                                          "type": "output",
                                          "label": "Refer to Insulin Initiator",
                                          "edge_label": ""
                                        }
                                      ]
                                    }
                                  ]
                                }
                              ]
                            }
                          ]
                        }
                      ]
                    }
                  ]
                },
                {
                  "id": "a4",
                  "type": "action",
                  "label": "Metformin",
                  "edge_label": "Not at risk of CVD",
                  "children": [
                    {
                      "id": "d6",
                      "type": "decision",
                      "label": "A1c not controlled Start Dual Therapy",
                      "input_ids": [],
                      "edge_label": "",
                      "children": [
                        {
                          "id": "o3",
                          "type": "output",
                          "label": "Gliptin",
                          "edge_label": ""
                        },
                        {
                          "id": "o4",
                          "type": "output",
                          "label": "Pioglitazone",
                          "edge_label": ""
                        },
                        {
                          "id": "o5",
                          "type": "output",
                          "label": "Gliclazide",
                          "edge_label": ""
                        }
                      ]
                    }
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  },
  "doubts": [
    "The diagram shows 'Not tolerated** switch to' from Metformin, but the destination is unclear. It appears to loop back to SGLT2i, but the workflow structure is ambiguous.",
    "After the dual therapy (Gliptin/Pioglitazone/Gliclazide), there is a 'A1c Not Controlled Start Triple Therapy' node that leads to triple therapy, then branches to 'Add GLP' and prognostic value decisions (High/Low), leading to Ozempic/Mounjaro, which eventually loops back to 'Refer to Insulin Initiator'. This creates a complex flow that's difficult to represent as a single rooted tree without creating disconnected paths or cycles.",
    "The 'Or' nodes between Gliptin, Pioglitazone, and Gliclazide suggest these are alternative options, but the tree structure requires each to be a separate child of the decision node.",
    "The prognostic value decision (High/Low) appears to determine whether to use Ozempic or Mounjaro, but the exact condition for this decision is not explicitly stated in terms of inputs."
  ],
  "variables": []
}